353 related articles for article (PubMed ID: 17536076)
1. Population-based incidence of type 2 diabetes in northern Spain: the Asturias Study.
Valdés S; Botas P; Delgado E; Alvarez F; Cadórniga FD
Diabetes Care; 2007 Sep; 30(9):2258-63. PubMed ID: 17536076
[TBL] [Abstract][Full Text] [Related]
2. Does the new American Diabetes Association definition for impaired fasting glucose improve its ability to predict type 2 diabetes mellitus in Spanish persons? The Asturias Study.
Valdés S; Botas P; Delgado E; Alvarez F; Cadórniga FD
Metabolism; 2008 Mar; 57(3):399-403. PubMed ID: 18249214
[TBL] [Abstract][Full Text] [Related]
3. [Prevalence of newly diagnosed type 2 diabetes, impaired glucose tolerance and abnormal fasting glucose in a high risk population. Data from the RIAD study using new diagnostic criteria for diabetes].
Köhler C; Temelkova-Kurktschiev T; Schaper F; Fücker K; Hanefeld M
Dtsch Med Wochenschr; 1999 Sep; 124(37):1057-61. PubMed ID: 10520305
[TBL] [Abstract][Full Text] [Related]
4. Incidence of type 2 diabetes in southern Spain (Pizarra Study).
Soriguer F; Rojo-Martínez G; Almaraz MC; Esteva I; Ruiz de Adana MS; Morcillo S; Valdés S; García-Fuentes E; García-Escobar E; Cardona I; Gomez-Zumaquero JM; Olveira-Fuster G
Eur J Clin Invest; 2008 Feb; 38(2):126-33. PubMed ID: 18226046
[TBL] [Abstract][Full Text] [Related]
5. Relative role of major risk factors for Type 2 diabetes development in the historical cohort of the Brisighella Heart Study: an 8-year follow-up.
Cicero AF; Dormi A; Nascetti S; Panourgia MP; Grandi E; D'Addato S; Gaddi A
Diabet Med; 2005 Sep; 22(9):1263-6. PubMed ID: 16108859
[TBL] [Abstract][Full Text] [Related]
6. High incidence of type 2 diabetes and increasing conversion rates from impaired fasting glucose and impaired glucose tolerance to diabetes in Mauritius.
Söderberg S; Zimmet P; Tuomilehto J; de Courten M; Dowse GK; Chitson P; Stenlund H; Gareeboo H; Alberti KG; Shaw J
J Intern Med; 2004 Jul; 256(1):37-47. PubMed ID: 15189364
[TBL] [Abstract][Full Text] [Related]
7. Glucose indices, health behaviors, and incidence of diabetes in Australia: the Australian Diabetes, Obesity and Lifestyle Study.
Magliano DJ; Barr EL; Zimmet PZ; Cameron AJ; Dunstan DW; Colagiuri S; Jolley D; Owen N; Phillips P; Tapp RJ; Welborn TA; Shaw JE
Diabetes Care; 2008 Feb; 31(2):267-72. PubMed ID: 17989310
[TBL] [Abstract][Full Text] [Related]
8. Incidence of Type 2 diabetes in England and its association with baseline impaired fasting glucose: the Ely study 1990-2000.
Forouhi NG; Luan J; Hennings S; Wareham NJ
Diabet Med; 2007 Feb; 24(2):200-7. PubMed ID: 17257284
[TBL] [Abstract][Full Text] [Related]
9. Diabetes, pre-diabetes and associated risks on Minnesota code-indicated major electrocardiogram abnormality among Chinese: a cross-sectional diabetic study in Fujian province, southeast China.
Lin L; Chen G; Zou X; Zhao J; Zhu F; Tu M; Xu S; Lin W; Yang S; Zhang Y; Lin M; Chen N; Huang H; Liang J; Li L; Yao J
Obes Rev; 2009 Jul; 10(4):420-30. PubMed ID: 19460110
[TBL] [Abstract][Full Text] [Related]
10. Incidence and predictors of abnormal fasting plasma glucose among the university hospital employees in Thailand.
Jiamjarasrangsi W; Lohsoonthorn V; Lertmaharit S; Sangwatanaroj S
Diabetes Res Clin Pract; 2008 Feb; 79(2):343-9. PubMed ID: 17953998
[TBL] [Abstract][Full Text] [Related]
11. Distribution of fasting plasma glucose and prevalence of impaired fasting glucose, impaired glucose tolerance and type 2 diabetes in the Mexican paediatric population.
Guerrero-Romero F; Violante R; Rodríguez-Morán M
Paediatr Perinat Epidemiol; 2009 Jul; 23(4):363-9. PubMed ID: 19523083
[TBL] [Abstract][Full Text] [Related]
12. Hypomagnesaemia and risk for metabolic glucose disorders: a 10-year follow-up study.
Guerrero-Romero F; Rascón-Pacheco RA; Rodríguez-Morán M; de la Peña JE; Wacher N
Eur J Clin Invest; 2008 Jun; 38(6):389-96. PubMed ID: 18489400
[TBL] [Abstract][Full Text] [Related]
13. Type II Diabetes Mellitus and impaired glucose tolerance in Yemen: prevalence, associated metabolic changes and risk factors.
Al-Habori M; Al-Mamari M; Al-Meeri A
Diabetes Res Clin Pract; 2004 Sep; 65(3):275-81. PubMed ID: 15331208
[TBL] [Abstract][Full Text] [Related]
14. Incidence of diabetes and pre-diabetes in a selected urban south Indian population (CUPS-19).
Mohan V; Deepa M; Anjana RM; Lanthorn H; Deepa R
J Assoc Physicians India; 2008 Mar; 56():152-7. PubMed ID: 18697630
[TBL] [Abstract][Full Text] [Related]
15. Associations of adiponectin levels with incident impaired glucose metabolism and type 2 diabetes in older men and women: the hoorn study.
Snijder MB; Heine RJ; Seidell JC; Bouter LM; Stehouwer CD; Nijpels G; Funahashi T; Matsuzawa Y; Shimomura I; Dekker JM
Diabetes Care; 2006 Nov; 29(11):2498-503. PubMed ID: 17065691
[TBL] [Abstract][Full Text] [Related]
16. Type 2 diabetes in southern Kerala: variation in prevalence among geographic divisions within a region.
Kutty VR; Soman CR; Joseph A; Pisharody R; Vijayakumar K
Natl Med J India; 2000; 13(6):287-92. PubMed ID: 11209482
[TBL] [Abstract][Full Text] [Related]
17. Glucose levels are associated with cardiovascular disease and death in an international cohort of normal glycaemic and dysglycaemic men and women: the EpiDREAM cohort study.
Anand SS; Dagenais GR; Mohan V; Diaz R; Probstfield J; Freeman R; Shaw J; Lanas F; Avezum A; Budaj A; Jung H; Desai D; Bosch J; Yusuf S; Gerstein HC;
Eur J Prev Cardiol; 2012 Aug; 19(4):755-64. PubMed ID: 21551215
[TBL] [Abstract][Full Text] [Related]
18. Change in prevalence and 6-year incidence of diabetes and impaired fasting glucose in Korean subjects living in a rural area.
Song KH; Nam-Goomg IS; Han SM; Kim MS; Lee EJ; Lee YS; Lee MS; Yoon S; Lee KU; Park JY
Diabetes Res Clin Pract; 2007 Dec; 78(3):378-84. PubMed ID: 17544540
[TBL] [Abstract][Full Text] [Related]
19. Impaired fasting glucose cutoff value of 5.6 mmol/l combined with other cardiovascular risk markers is a better predictor for incident Type 2 diabetes than the 6.1 mmol/l value: Tehran lipid and glucose study.
Harati H; Hadaegh F; Tohidi M; Azizi F
Diabetes Res Clin Pract; 2009 Jul; 85(1):90-5. PubMed ID: 19414206
[TBL] [Abstract][Full Text] [Related]
20. Low levels of insulin-like growth-factor-binding protein-1 (IGFBP-1) are prospectively associated with the incidence of type 2 diabetes and impaired glucose tolerance (IGT): the Söderåkra Cardiovascular Risk Factor Study.
Petersson U; Ostgren CJ; Brudin L; Brismar K; Nilsson PM
Diabetes Metab; 2009 Jun; 35(3):198-205. PubMed ID: 19297224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
